ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 142 filers reported holding ENANTA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $113 | -47.4% | 10,112 | +0.6% | 0.00% | – |
| Q2 2023 | $215 | -46.2% | 10,056 | +1.6% | 0.00% | -100.0% |
| Q1 2023 | $400 | -41.5% | 9,900 | -32.7% | 0.00% | 0.0% |
| Q4 2022 | $684 | -99.9% | 14,700 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $762,000 | +9.6% | 14,700 | -0.0% | 0.00% | 0.0% |
| Q2 2022 | $695,000 | -50.0% | 14,705 | -24.7% | 0.00% | 0.0% |
| Q1 2022 | $1,391,000 | -39.8% | 19,541 | -36.8% | 0.00% | -50.0% |
| Q4 2021 | $2,311,000 | +29.8% | 30,906 | -1.4% | 0.00% | 0.0% |
| Q3 2021 | $1,781,000 | +20.1% | 31,354 | -7.0% | 0.00% | 0.0% |
| Q2 2021 | $1,483,000 | -20.7% | 33,707 | -11.1% | 0.00% | 0.0% |
| Q1 2021 | $1,869,000 | +17.1% | 37,898 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $1,596,000 | +11.2% | 37,898 | +20.9% | 0.00% | 0.0% |
| Q3 2020 | $1,435,000 | -8.8% | 31,348 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $1,574,000 | +34.2% | 31,348 | +37.5% | 0.00% | 0.0% |
| Q1 2020 | $1,173,000 | -16.3% | 22,798 | +0.4% | 0.00% | 0.0% |
| Q4 2019 | $1,402,000 | -11.6% | 22,698 | -14.0% | 0.00% | 0.0% |
| Q3 2019 | $1,586,000 | -44.9% | 26,398 | -22.7% | 0.00% | -50.0% |
| Q2 2019 | $2,881,000 | -12.4% | 34,147 | -0.9% | 0.00% | 0.0% |
| Q1 2019 | $3,290,000 | +35.6% | 34,447 | +0.6% | 0.00% | 0.0% |
| Q4 2018 | $2,426,000 | -25.0% | 34,247 | -9.5% | 0.00% | 0.0% |
| Q3 2018 | $3,234,000 | -30.4% | 37,837 | -5.6% | 0.00% | -33.3% |
| Q2 2018 | $4,645,000 | +70.0% | 40,079 | +18.7% | 0.01% | +100.0% |
| Q1 2018 | $2,733,000 | +18.7% | 33,773 | -13.9% | 0.00% | 0.0% |
| Q4 2017 | $2,302,000 | -0.5% | 39,238 | -20.6% | 0.00% | 0.0% |
| Q3 2017 | $2,313,000 | +73.4% | 49,418 | +33.3% | 0.00% | +50.0% |
| Q2 2017 | $1,334,000 | -1.0% | 37,078 | -15.3% | 0.00% | 0.0% |
| Q1 2017 | $1,348,000 | -6.1% | 43,775 | +2.1% | 0.00% | 0.0% |
| Q4 2016 | $1,436,000 | +34.8% | 42,874 | +7.2% | 0.00% | 0.0% |
| Q3 2016 | $1,065,000 | -66.7% | 40,010 | -72.4% | 0.00% | -60.0% |
| Q2 2016 | $3,198,000 | -22.7% | 145,024 | +3.0% | 0.01% | -16.7% |
| Q1 2016 | $4,137,000 | -6.2% | 140,850 | +5.5% | 0.01% | -14.3% |
| Q4 2015 | $4,410,000 | -1.3% | 133,569 | +8.0% | 0.01% | 0.0% |
| Q3 2015 | $4,470,000 | -16.9% | 123,698 | +3.4% | 0.01% | -12.5% |
| Q2 2015 | $5,381,000 | +67.3% | 119,614 | +13.9% | 0.01% | +60.0% |
| Q1 2015 | $3,216,000 | +8.6% | 105,014 | +80.3% | 0.01% | +25.0% |
| Q4 2014 | $2,962,000 | +81.4% | 58,246 | +41.1% | 0.00% | +100.0% |
| Q3 2014 | $1,633,000 | -33.7% | 41,270 | -27.8% | 0.00% | -50.0% |
| Q2 2014 | $2,464,000 | – | 57,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 858,811 | $36,156,000 | 10.56% |
| Fairmount Funds Management LLC | 150,433 | $6,333,000 | 2.26% |
| ARMISTICE CAPITAL, LLC | 1,356,000 | $57,088,000 | 1.94% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,775,000 | $74,728,000 | 0.45% |
| Virtus ETF Advisers LLC | 14,321 | $603,000 | 0.25% |
| Granahan Investment Management | 231,071 | $9,728,000 | 0.22% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 248,320 | $10,454,000 | 0.09% |
| ACADIAN ASSET MANAGEMENT LLC | 467,514 | $19,684,000 | 0.08% |
| VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. | 126 | $5,000 | 0.08% |
| AIGEN INVESTMENT MANAGEMENT, LP | 12,854 | $541,000 | 0.07% |